» Articles » PMID: 30250260

Protein Misfolding, Aggregation, and Conformational Strains in Neurodegenerative Diseases

Overview
Journal Nat Neurosci
Date 2018 Sep 26
PMID 30250260
Citations 413
Authors
Affiliations
Soon will be listed here.
Abstract

A hallmark event in neurodegenerative diseases (NDs) is the misfolding, aggregation, and accumulation of proteins, leading to cellular dysfunction, loss of synaptic connections, and brain damage. Despite the involvement of distinct proteins in different NDs, the process of protein misfolding and aggregation is remarkably similar. A recent breakthrough in the field was the discovery that misfolded protein aggregates can self-propagate through seeding and spread the pathological abnormalities between cells and tissues in a manner akin to the behavior of infectious prions in prion diseases. This discovery has vast implications for understanding the mechanisms involved in the initiation and progression of NDs, as well as for the design of novel strategies for treatment and diagnosis. In this Review, we provide a critical discussion of the role of protein misfolding and aggregation in NDs. Commonalities and differences between distinct protein aggregates will be highlighted, in addition to evidence supporting the hypothesis that misfolded aggregates can be transmissible by the prion principle. We will also describe the molecular basis and implications for prion-like conformational strains, cross-interaction between different misfolded proteins in the brain, and how these concepts can be applied to the development of novel strategies for therapy and diagnosis.

Citing Articles

Small Heat Shock Proteins: Protein Aggregation Amelioration and Neuro- and Age-Protective Roles.

Albinhassan T, Alharbi B, AlSuhaibani E, Mohammad S, Malik S Int J Mol Sci. 2025; 26(4).

PMID: 40003991 PMC: 11855743. DOI: 10.3390/ijms26041525.


Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.

Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla V, Sakharkar M ACS Omega. 2025; 10(6):5148-5171.

PMID: 39989768 PMC: 11840625. DOI: 10.1021/acsomega.4c05527.


Engineered Extracellular Vesicles as a New Class of Nanomedicine.

Wen X, Hao Z, Yin H, Min J, Wang X, Sun S Chem Bio Eng. 2025; 2(1):3-22.

PMID: 39975802 PMC: 11835263. DOI: 10.1021/cbe.4c00122.


Innate and adaptive immunity in neurodegenerative disease.

Huang Y, Zhang G, Li S, Feng J, Zhang Z Cell Mol Life Sci. 2025; 82(1):68.

PMID: 39894884 PMC: 11788272. DOI: 10.1007/s00018-024-05533-4.


Toward a biological definition of neuronal and glial synucleinopathies.

Soto C, Mollenhauer B, Hansson O, Kang U, Alcalay R, Standaert D Nat Med. 2025; 31(2):396-408.

PMID: 39885358 DOI: 10.1038/s41591-024-03469-7.


References
1.
Fitzpatrick A, Falcon B, He S, Murzin A, Murshudov G, Garringer H . Cryo-EM structures of tau filaments from Alzheimer's disease. Nature. 2017; 547(7662):185-190. PMC: 5552202. DOI: 10.1038/nature23002. View

2.
McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

3.
Pigott K, Rick J, Xie S, Hurtig H, Chen-Plotkin A, Duda J . Longitudinal study of normal cognition in Parkinson disease. Neurology. 2015; 85(15):1276-82. PMC: 4617168. DOI: 10.1212/WNL.0000000000002001. View

4.
Kaufman S, Sanders D, Thomas T, Ruchinskas A, Vaquer-Alicea J, Sharma A . Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Neuron. 2016; 92(4):796-812. PMC: 5392364. DOI: 10.1016/j.neuron.2016.09.055. View

5.
Danzer K, Kranich L, Ruf W, Cagsal-Getkin O, Winslow A, Zhu L . Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012; 7:42. PMC: 3483256. DOI: 10.1186/1750-1326-7-42. View